USPTO Examiner TURK NEIL N - Art Unit 1798

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18762916METHOD FOR DETERMINING CIPROFLOXACIN IN MEAT PRODUCT BASED ON ENZYME-LINKED UPCONVERSION FLUORESCENCE AND POTASSIUM TITANIUM OXALATE SYSTEMJuly 2024February 2025Allow710NoNo
18421626CELL COLONY PICKING SYSTEMJanuary 2024August 2024Allow600YesNo
18530979NEPHELMOTRIC MEASURING DEVICE(S)December 2023March 2025Allow1511YesNo
18500236METHOD AND SYSTEM FOR FLUORESCENCE LIFETIME BASED SEQUENCINGNovember 2023August 2024Allow900YesNo
18489187FECES COLOR DETECTION DEVICEOctober 2023September 2024Allow1110YesNo
18377880ALARM METHOD, SYSTEM AND STORAGE MEDIUM FOR ABNORMALITIES OF SAMPLE ANALYZEROctober 2023August 2024Allow1110NoNo
18456322Methods and Compositions for Highly Sensitive Detection of MoleculesAugust 2023March 2025Abandon1810NoNo
18361434METHODS AND COMPOSITIONS FOR INCORPORATING NUCLEOTIDESJuly 2023April 2025Allow2020YesNo
18339185Biosensors for Biological or Chemical Analysis and Methods of Manufacturing the SameJune 2023July 2024Allow1300YesNo
18209005SAMPLE COLLECTION SYSTEM INCLUDING VALVE ASSEMBLYJune 2023April 2024Allow1100YesNo
18208980SAMPLE COLLECTION SYSTEM INCLUDING VALVE ASSEMBLYJune 2023April 2024Allow1100YesNo
18204120SAMPLE COLLECTION SYSTEM INCLUDING PLUG ASSEMBLYMay 2023April 2024Allow1010YesNo
18037322IMMUNOCHROMATOGRAPHIC KIT FOR FLUORESCENT IMMUNOCHROMATOGRAPHY AND HOUSING CASE COMPRISING IMMUNOCHROMATOGRAPHIC KITMay 2023August 2024Abandon1520NoNo
18180628SPECTROGRAPHIC DETECTION OF ACUTE LEUKEMIAMarch 2023November 2024Abandon2030NoNo
18111865AUTOMATED SAMPLE HANDLING INSTRUMENTATION, SYSTEMS, PROCESSES, AND METHODSFebruary 2023July 2023Allow400YesNo
18149811RAPID PRETREATMENTJanuary 2023March 2024Allow1520YesNo
18087787BIOLOGICAL MATERIAL MEASURING INSTRUMENTDecember 2022April 2024Allow1610YesNo
17989666Methods and Systems for Point-of-Care Sample AnalysisNovember 2022June 2024Abandon1910NoNo
17885687ASSAY DEVICE EMPLOYING FLUORESCENT LABELSAugust 2022June 2024Abandon2210NoNo
17818637BIOCHIP DEVICEAugust 2022February 2024Allow1820YesNo
17818612BIOCHIP DEVICEAugust 2022December 2024Abandon2840YesNo
17855929SYSTEMS AND METHODS FOR SORTING T CELLS BY ACTIVATION STATEJuly 2022February 2024Allow2011YesNo
17663779FLASH-TYPE CHEMILUMINESCENCE SYSTEM BASED ON CUINS2@ZNS NANOMATERIALMay 2022October 2022Allow510YesNo
17663495SINGLE-USE TEST DEVICE FOR IMAGING BLOOD CELLSMay 2022October 2023Abandon1710NoNo
17619799AGENT FOR REGULATING CONCENTRATION OF GAS FOR ANAEROBIC BACTERIUM CULTURE AND METHOD FOR CULTURING ANAEROBIC BACTERIUM USING SAMEDecember 2021January 2025Allow3810YesNo
17509119CELL CULTURE SYSTEMOctober 2021January 2025Allow3910YesNo
17605925ARBITRARILY SHAPED, DEEP SUB-WAVELENGTH ACOUSTIC MANIPULATION FOR MICROPARTICLE AND CELL PATTERNINGOctober 2021December 2024Allow3810YesNo
17501387METHOD FOR ANALYZING GLYCOSAMINOGLYCANOctober 2021September 2024Allow3530NoNo
17497325COMPOSITION AND METHOD FOR MONITORING LIPIDOctober 2021November 2023Abandon2510NoNo
17488619NUCLEIC ACID DETECTION KIT AND NUCLEIC ACID DETECTION DEVICESeptember 2021June 2024Abandon3210NoNo
17448801PROCESS FOR MICROBIAL SYNTHESIS AND AN APPARATUS THEREOFSeptember 2021February 2025Allow4011NoNo
17474586Automated Analyzer and Automated Analysis MethodSeptember 2021August 2024Allow3530YesNo
17470615SYSTEMS AND METHODS FOR FACILITATING FLUID FLOW DURING ENHANCED DETECTION AND QUANTIFICATION OF ANALYTESSeptember 2021March 2024Allow3120YesNo
17465049READER DEVICE FOR LUMINESCENT IMMUNOASSAYSSeptember 2021March 2025Allow4230YesYes
17433100NEPHELOMETRIC MEASURING DEVICE(S)August 2021November 2023Allow2631YesNo
17405379BIOSENSORS FOR BIOLOGICAL OR CHEMICAL ANALYSIS AND METHODS OF MANUFACTURING THE SAMEAugust 2021March 2023Allow1900YesNo
17396477METHOD FOR ORGANIZING INDIVIDUAL MOLECULES ON A PATTERNED SUBSTRATE AND STRUCTURES ASSEMBLED THEREBYAugust 2021April 2025Allow4420YesNo
17429092APPARTATUS AND METHODS FOR REAL-TIME CELL MONITORINGAugust 2021March 2025Abandon4410NoNo
17427105CHEMILUMINESCENCE IMMUNOASSAY ANALYZERJuly 2021November 2022Allow1510YesNo
17426778Modular Kit for Integration and Installation of One or More Bioreactors for Microalgae CultivationJuly 2021August 2024Allow3600YesNo
17380459OPTICAL MEASUREMENT DEVICE FOR REACTION VESSEL AND METHOD THEREFORJuly 2021March 2023Allow2000YesNo
17419206CELL PROCESSING PLATFORM CELL PROCESSING SYSTEM AND METHODS OF USE THEREOFJune 2021April 2025Abandon4610NoNo
17357203DIAGNOSTIC DEVICE WITH DUAL-REGION SUBSTRATEJune 2021March 2025Abandon4501NoNo
17414051CELL ANALYSIS SYSTEMSJune 2021December 2024Abandon4210NoNo
17312960USE OF VISION SYSTEMS IN BIOMANUFACTURING PROCESSESJune 2021January 2025Abandon4301NoNo
17323176SYSTEM FOR IMAGING CAPTURED CELLSMay 2021September 2021Allow401NoNo
17314518OPTIMIZED OPTICAL SETUP TO MAXIMIZE FLUORESCENCE DETECTION IN SAMPLESMay 2021April 2024Abandon3620NoNo
17307341DETERMINATION OF WATER TREATMENT PARAMETERS BASED ON ABSORBANCE AND FLUORESCENCEMay 2021September 2023Allow2810YesNo
17240429FLOW CYTOMETERS INCLUDING LASER ASSESSORS, AND METHODS FOR USING THE SAMEApril 2021November 2024Allow4241YesNo
17210832VIRUS DETECTION SYSTEMMarch 2021September 2023Allow3011YesNo
17209846CELL CULTURING DEVICE AND CELL CULTURING METHODMarch 2021October 2024Abandon4210NoNo
17204276WAVEGUIDE ENHANCED ANALYTE DETECTION APPARATUSMarch 2021June 2023Allow2700YesNo
17204335DOCKING STATION WITH WAVEGUIDE ENHANCED ANALYTE DETECTION STRIPMarch 2021June 2023Allow2720YesNo
17188960Methods and Compositions for Highly Sensitive Detection of MoleculesMarch 2021November 2023Abandon3220NoNo
17187498Method of Detecting an Analyte in a SampleFebruary 2021November 2024Abandon4410NoNo
17268450Systems and Methods for Measuring Composition of WaterFebruary 2021June 2025Allow5240YesNo
17164203APPARATUS AND METHOD FOR DIRECTING A LIQUID THROUGH A POROUS MEDIUMFebruary 2021January 2025Allow4820YesNo
17159204AUTOMATIC ANALYSIS DEVICEJanuary 2021October 2022Allow2100YesNo
17261623LATERAL FLOW TEST STRIP IMMUNOASSAY IN VITRO DIAGNOSTIC DEVICEJanuary 2021September 2024Abandon4420YesNo
17135595METHOD AND SYSTEM FOR FLUORESCENCE LIFETIME BASED SEQUENCINGDecember 2020August 2023Allow3111YesNo
17132046BIOLOGICAL SAMPLE HOLDER AND HANDLERDecember 2020January 2024Abandon3610NoNo
17129522AUTOMATED CONTAINER CAPPING/DECAPPING MECHANISMDecember 2020November 2022Allow2300YesNo
17254794SYSTEMS AND METHODS FOR NORMALIZING SIGNALS IN BLOOD CULTURE MEASUREMENT SYSTEMSDecember 2020May 2023Allow2900YesNo
17127042BIOCONTAINER ASSEMBLY FOR BIOPROCESSING SYSTEMDecember 2020May 2025Allow5320YesNo
17124789EXAMINATION DEVISE, CONTAINER USED WITH EXAMINATION DEVICE, AND MANUFACTURING METHOD OF CONTAINER USED WITH EXAMINATION DEVICEDecember 2020May 2024Abandon4120YesNo
17107278OPEN CHAMBER ACOUSTIC DEVICE TO MEASURE CELL BINDING FORCENovember 2020July 2024Allow4421NoNo
17059732NUCLEIC ACID DETECTIONNovember 2020July 2023Allow3230YesNo
17052136NANO ENCODING TECHNOLOGY FOR THE TRACKING OF INFORMATION IN LIQUID SAMPLESOctober 2020August 2023Allow3310NoNo
17083182METHOD FOR CALIBRATING FLUORESCENT PLATE READERSOctober 2020June 2024Allow4430YesNo
17078435Chromatography MediumOctober 2020April 2024Allow4240YesNo
17079405PHYTOPATHOGENIC FUNGUS DETECTING APPARATUS, AND DETECTING METHOD AND METHOD FOR SELECTING CONCENTRATION OF AGRICULTURAL CHEMICAL USING SAMEOctober 2020April 2024Allow4210YesNo
17078705ALARM METHOD, SYSTEM AND STORAGE MEDIUM FOR ABNORMALITIES OF SAMPLE ANALYZEROctober 2020June 2023Allow3210YesNo
17077660Methods and Systems for Point-of-Care Sample AnalysisOctober 2020November 2022Abandon2510NoNo
17076269RAPID PRETREATMENTOctober 2020January 2023Abandon2720NoNo
17049142ANALYTE CAPTURING DEVICES WITH FLUIDIC EJECTION DEVICESOctober 2020July 2024Abandon4511NoNo
17049302MICROFLUIDIC DEVICES WITH IMPEDANCE SETTING TO SET BACKPRESSUREOctober 2020March 2024Abandon4110NoNo
17070308SYSTEM, APPARATUS, AND METHOD FOR VIRAL MONITORING IN EFFLUENTOctober 2020May 2024Abandon4350NoNo
17045750Device for a Light Spectroscopic AnalysisOctober 2020September 2023Allow3520YesNo
17036875METHOD AND APPARATUS FOR CODING DIAGNOSTIC METERSSeptember 2020September 2022Allow2420YesNo
16976757IN-SITU PHOTOCATALYSIS MONITORING SYSTEM BASED ON SURFACE-ENHANCED RAMAN SCATTERING SPECTROSCOPYAugust 2020November 2020Allow200YesNo
17000994TISSUE PROCESSINGAugust 2020October 2022Allow2520YesNo
16998776Reagents, Systems and Methods for Analyzing White Blood CellsAugust 2020July 2024Abandon4710NoNo
16993823OPTOCHEMICAL SENSOR AND METHODAugust 2020September 2022Allow2520YesNo
16984011INTEGRATED DISSOLUTION PROCESSING AND SAMPLE TRANSFER SYSTEMAugust 2020June 2023Allow3430YesNo
16965242MOVEMENT METHOD AND MOVEMENT DEVICE FOR BIOLOGICAL SUBJECTJuly 2020March 2024Abandon4310NoNo
16964193NUCLEOTIDE SEQUENCING ELEMENT AND CHIP, AND SEQUENCING ANALYSIS METHODJuly 2020May 2024Abandon4510NoNo
16906830SAMPLE COLLECTION SYSTEM INCLUDING VALVE AND PLUG ASSEMBLIESJune 2020March 2023Allow3210YesNo
16954100Synthetic Fluorescent Protein Biosensors and Use Thereof in Drug Screening MethodsJune 2020November 2023Abandon4110NoNo
16769422METHODS FOR ANALYSIS OF SINGLE MOLECULE LOCALIZATION MICROSCOPY TO DEFINE MOLECULAR ARCHITECTUREJune 2020May 2024Allow4830YesNo
16888047MICROFLUIDIC DETERMINATION OF LOW ABUNDANCE EVENTSMay 2020November 2020Allow510NoNo
16765880BIOLOGICAL GAS (VOCs) MEASUREMENT DEVICEMay 2020November 2023Abandon4110NoNo
16876562Apparatus For Tissue Lysis Under Electromagnetic Field ControlMay 2020February 2024Allow4520YesNo
16857634BIOSENSORApril 2020October 2020Allow610YesNo
16651322ANALYTICAL SYSTEM FOR MOLECULE DETECTION AND SENSINGMarch 2020July 2023Allow4021YesNo
16646386Automated Analyzer and Automated Analysis MethodMarch 2020July 2021Allow1620YesNo
16814846METHODS AND APPARATUSES FOR IDENTIFYING RED BLOOD CELLS INFECTED BY PLASMODIUMMarch 2020April 2022Abandon2511YesNo
16814643POLYMER MATRIX FOR SENSINGMarch 2020May 2024Abandon5050YesNo
16644587FILTRATION ASSEMBLY AND METHOD FOR MICROBIOLOGICAL TESTINGMarch 2020January 2023Allow3520YesNo
16643917AUTOMATED ANALYZERMarch 2020July 2023Abandon4080YesNo
16640149ASSAYS WITH REDUCED INTERFERENCEFebruary 2020January 2023Abandon3481NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner TURK, NEIL N.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
32
Examiner Affirmed
14
(43.8%)
Examiner Reversed
18
(56.2%)
Reversal Percentile
81.4%
Higher than average

What This Means

With a 56.2% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
57
Allowed After Appeal Filing
23
(40.4%)
Not Allowed After Appeal Filing
34
(59.6%)
Filing Benefit Percentile
65.1%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 40.4% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner TURK, NEIL N - Prosecution Strategy Guide

Executive Summary

Examiner TURK, NEIL N works in Art Unit 1798 and has examined 466 patent applications in our dataset. With an allowance rate of 54.5%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 39 months.

Allowance Patterns

Examiner TURK, NEIL N's allowance rate of 54.5% places them in the 10% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by TURK, NEIL N receive 2.94 office actions before reaching final disposition. This places the examiner in the 94% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by TURK, NEIL N is 39 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +46.9% benefit to allowance rate for applications examined by TURK, NEIL N. This interview benefit is in the 93% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 16.3% of applications are subsequently allowed. This success rate is in the 7% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 12.0% of cases where such amendments are filed. This entry rate is in the 6% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 37.5% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 33% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 52.9% of appeals filed. This is in the 19% percentile among all examiners. Of these withdrawals, 25.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 55.7% are granted (fully or in part). This grant rate is in the 70% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.4% of allowed cases (in the 58% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.8% of allowed cases (in the 54% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.